Experimental and clinical studies with somatostatin analogue octreotide in small cell lung cancer
- 1 September 1991
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 64 (3), 451-456
- https://doi.org/10.1038/bjc.1991.330
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Inhibition of growth of human breast carcinomas in vivo by somatostatin analog SMS 201-995: treatment of nude mouse xenografts.1989
- SOMATOSTATIN ANALOG SMS 201-995 REDUCES SERUM IGF-I LEVELS IN PATIENTS WITH NEOPLASMS POTENTIALLY DEPENDENT ON IGF-I1989
- Somatostatin and somatostatin analogues in oncologyCancer Treatment Reviews, 1989
- Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase.Proceedings of the National Academy of Sciences, 1989
- Somatostatin and Somatostatin Analogue (SMS 201-995) in Treatment of Hormone-Secreting Tumors of the Pituitary and Gastrointestinal Tract and Non-Neoplastic Diseases of the GutAnnals of Internal Medicine, 1989
- Neuron-specific enolase: How useful as a cancer marker?European Journal of Cancer and Clinical Oncology, 1988
- High affinity binding of [125I-Tyr11]somatostatin-14 to human small cell lung carcinoma (NCI-H69)Life Sciences, 1988
- SOMATOSTATIN RECEPTORS IN HUMAN ENDOCRINE TUMORS1987
- Treatment of the Malignant Carcinoid SyndromeNew England Journal of Medicine, 1986
- The Measurement of Insulin-Like Growth Factor I: Clinical Applications and SignificanceAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1986